| Display this index in Date order |
| Title & Synopsis | Date |
Price |
Order Form
|
| All Change in the US Pharma Market? This extensive report provides a unique analysis of the likely impact of generic competition in the US pharma market. More>> |
Jun-2008 |
£995/
$1740/
€1245 |
|
| Biopharmaceuticals in South East Asia This detailed report analyses the market and research environments, assessing risk and identifying opportunity in Indonesia, Malaysia, Singapore, South Korea, Taiwan and Thailand. More>> |
Jul-2008 |
£795/
$1390/
€995 |
|
| E7: The Outlook for Pharmaceuticals The E7 economies have widely differing healthcare systems and priorities, making a detailed knowledge of the background to the market essential for strategic assessment. E7: The Outlook for Pharmaceuticals provides an individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. More>> |
May-2010 |
£1995/
$3490/
€2495 |
|
| Emerging Generic Drug Markets in Europe The four EU countries analysed in this report - France, Italy, Portugal, Spain - are expected to deliver significant double digit growth over the next 5 years and present stable, regulated operating environments with excellent prospects. More>> |
Dec-2007 |
£795/
$1390/
€995 |
|
| Opportunities and Challenges for Bioequivalent Generic Drugs in Brazil This new report puts the generic market in context, providing a review of the regulatory environment, the major domestic manufacturers, market analysis and five-year market forecasts to 2012. More>> |
Apr-2007 |
£795/
$1390/
€995 |
|
| Opportunities and Challenges for Generic Drugs in Australia This report provides a complete assessment of the US$1.43 billion Australian generic pharmaceutical market. More>> |
Mar-2008 |
£495/
$865/
€620 |
|
| Opportunities and Challenges for Generic Drugs in the UK The UK generic market is one of the world's largest in terms of both size and generic penetration. This report provides sets generics into the context of the pharmaceutical market as a whole, assesses the market outlook and provides forecasts to 2012. It includes an insightful review of major players in the market and detailed listing of leading products including prescription data, price comparisons and marketing authorisations. All you need to know for an informed business judgement! More>> |
Jun-2007 |
£795/
$1390/
€995 |
|
| The Latin American Market for Generic Drugs Rapid growth, high unmet clinical needs and increasing regulation are changing the face of Latin American pharmaceuticals. What are the opportunities and challenges for companies and investors wanting to develop or enter this growing market? This major strategic study compares 7 key markets. More>> |
Apr-2006 |
£995/
$1740/
€1245 |
|
| The Market for Pharmaceuticals in Brazil, Russia, India & China Evaluate the status, opportunities and threats for pharmaceutical companies in Brazil, Russia, India and China now and in the future. Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. The reports are updated quarterly and a comprehensive statistical appendix is included. More>> |
May-2010 |
£1695/
$2965/
€2120 |
|
| The Outlook for Emerging Central American Pharmaceutical Markets Incorporating much original information, this report shines a critical light on seven markets in the region, assessing their status and potential in the current economic and market conditions: Costa Rica, El Salvador, Honduras, Guatemala, Mexico, Nicaragua and Panama. More>> |
Jan-2009 |
£795/
$1390/
€995 |
|
| The Outlook for Pharmaceuticals in Central Asia Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. The reports are updated quarterly and a comprehensive statistical appendix is included. More>> |
May-2010 |
£1995/
$3490/
€2495 |
|
| The Outlook for Pharmaceuticals in Central & Eastern Europe Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. The reports are updated quarterly and a comprehensive statistical appendix is included. More>> |
May-2010 |
£1995/
$3490/
€2495 |
|
| The Outlook for Pharmaceuticals in Latin America Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. The reports are updated quarterly and a comprehensive statistical appendix is included. More>> |
May-2010 |
£1995/
$3490/
€2495 |
|
| The Outlook for Pharmaceuticals in North East Asia Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. The reports are updated quarterly and a comprehensive statistical appendix is included. More>> |
May-2010 |
£1995/
$3490/
€2495 |
|
| The Outlook for Pharmaceuticals in Northern Europe Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. The reports are updated quarterly and a comprehensive statistical appendix is included. More>> |
May-2010 |
£1995/
$3490/
€2495 |
|
| The Outlook for Pharmaceuticals in South East Asia Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. The reports are updated quarterly and a comprehensive statistical appendix is included. More>> |
May-2010 |
£1995/
$3490/
€2495 |
|
| The Outlook for Pharmaceuticals in Western Europe Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. The reports are updated quarterly and a comprehensive statistical appendix is included. More>> |
May-2010 |
£1995/
$3490/
€2495 |
|
| The Pharmaceutical Market: Argentina The Argentinian pharmacy sector, traditionally dominated by branded products, has shown an impressive double-digit growth in recent years. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Australia Australia represents a highly advanced pharmaceutical market. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Austria In an effort to streamline public services, Austria has been one of the first European countries to issue an electronic card that contains patient information. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Bangladesh Bangladesh has a large generics market, and companies such as Square and Beximco are beginning to have success overseas. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Belgium Pharmaceutical consumption in Belgium is comparatively high, although the complicated reimbursement system has hindered access to innovative drugs in the past. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Brazil Brazil is the second most attractive BRIC market for pharmaceutical producers. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Bulgaria Funding for healthcare in Bulgaria is principally through compulsory health insurance, operated by the National Health Insurance Fund. The role of the NHIF is to provide a basic package of health services for the whole population. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Canada Canada’s domestic pharmaceutical manufacturing sector is sizeable, but concentrates on generic drugs. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Chile The Chilean pharmaceutical market is the sixth largest market in the region, after Mexico, Brazil, Argentina, Venezuela and Colombia. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: China China is the world's most populous country and fastest growing major economy. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Colombia The Colombian pharmaceutical market is the fifth largest in Latin America. The majority of the market is supplied by the relatively well-developed domestic industry. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Croatia The pharmaceutical industry in Croatia is relatively small and is dominated by local and regional generic suppliers. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Cuba Cuba is one of the world's last unreconstructed communist countries. The country has a reputation for the quality of its health services and health indicators, and has an impressive pharmaceutical/biotechnology research sector. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Czech Republic The Czech pharmaceutical sector remains one of the better regional prospects for overseas suppliers, being relatively wealthy and largely reliant on imported medicines. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Denmark The Danish pharmaceutical market is small but very wealthy. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Egypt The Egyptian pharmaceutical market is the largest in the Middle East. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Estonia The Estonian healthcare system is currently being transformed from a state-controlled hospital-based system to a decentralised Western European-style model. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Finland Finland's pharmaceutical market is equivalent in size to Argentina, yet is on a par with Switzerland in terms of per capita expenditure. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: France France has one of the highest per capita consumptions of medicines in the world. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Germany Germany is the third largest pharmaceutical market in the world and the largest in Europe. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Greece As part of the EU, access to the Greek pharmaceutical market is governed by EU directives concerning pharmaceutical regulations and registration. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Hong Kong Hong Kong is really a city state, but the high level of wealth means that its healthcare provisions are of the very highest standard. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Hungary Hungary represents one of the more advanced pharmaceutical markets of Central Europe. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: India The vast majority of pharmaceuticals available in India are already off patent and generics are likely to dominate the market for the foreseeable future. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Indonesia Indonesia has a massive generics market, which is likely to see consolidation in 2010 as larger companies, such as Kalbe Farma, seek to maximise profits through acquisitions of smaller domestic companies. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Ireland The Republic of Ireland represents a small but advanced market for pharmaceuticals. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Israel The Israeli pharmaceutical market grew strongly in the 1990s, averaging around 10% per annum, although this has slowly been tempered to the 5.3% estimated for 2008, partly due to the economic slow-down. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Italy The demographic make up of the Italian population ensures that its pharmaceutical market remains the fourth largest in Europe, despite the industry having the lowest growth rate of all the developed economies. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Japan Japan remains the world's second largest pharmaceutical market, after the USA. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Jordan Jordan has a relatively strong level of domestic pharmaceutical production; however, the majority is exported, resulting in a market still dependent on imports. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Latvia Around 70% of the Latvian pharmaceutical market is supplied by imports from other European countries, as local production is limited and mainly geared towards exports. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Lithuania The Lithuanian pharmaceutical market is small and predominantly supplied by overseas manufacturers. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Malaysia The Malaysian pharmaceutical market continues to rely heavily on imports. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Mexico The Mexican generics market, which relies on public sales rather than private pharmacy sales, is expected to double in size in 2010. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Morocco Morocco has entered a new phase of development with the adoption of a modern legal framework for the pharmaceutical sector. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Netherlands Despite cost-cutting measures the Dutch pharmaceutical market remains advanced and stable. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: New Zealand The pharmaceutical market in New Zealand is experiencing limited growth due to a relatively low-growth economy with an ageing population. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Norway Overall the pharmaceutical market in Norway has been growing steadily, nonetheless it is beginning to slow down. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Pakistan Healthcare in Pakistan is still in the early stages of development. Widespread poverty and a weak health system underlie the poor health status of the population. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Peru The pharmaceutical market in Peru has increased slowly, although it is highly reliant on out-of-pocket expenditure. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Philippines Changes to be brought by the controversial Cheaper Medicine Bill will impact the Philippines pharmaceutical market in a number of areas, including IP laws, competition and drug price control mechanisms. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Poland In 2010, the Polish market for pharmaceuticals is twice that of Hungary; in per capita terms, the market is similar to Croatia. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Portugal A growing generics sector in Portugal is containing pharmacy sales. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Romania Around 86% of Romania's pharmaceutical market is supplied by imports. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Russia Around three quarters of the Russian pharmaceutical market is supplied by imports as the domestic production of innovative pharmaceuticals is negligible. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Saudi Arabia Multinational manufacturers, who for years have enjoyed a relative free hand in supplying the Saudi Arabian pharmaceutical market with little obstruction, are beginning to feel the heat. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Serbia Serbia has a small pharmaceutical industry, although this is expected to expand as manufacturers begin to operate in accordance with GMP standards, making their products more appealing to Western Europe. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Singapore Singapore is one of the most open economies in the world, and remains a popular destination for companies using the country as a trading base for the South East Asian region. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Slovakia Approximately 77% of the Slovakian pharmaceutical market is supplied by imports and domestic production concentrates principally on generic drugs. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Slovenia Slovenia has a sizeable domestic industry and is home to the two largest generics companies in Europe, Krka and Lek. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: South Africa Although the pharmaceutical market in South Africa continues to see a low level of growth, many of the major international manufacturers are present in the market, either through direct manufacturing facilities, licensing agreements with local producers or distribution operations. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: South Korea With a comprehensive health insurance system that covers the entire population South Korea’s pharmaceutical expenditure has risen steadily over the years. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Spain The Spanish pharmaceutical market is the fifth largest in the EU-27. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Sweden Pharmaceutical sector activity in Sweden is focused around cost containment. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Switzerland In Switzerland, a number of specific measures have been brought in to rein in costs and the promotion of generics has been at the forefront. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Taiwan Taiwan represents a major market for imported, advanced drugs, with per capita spending on pharmaceuticals among the highest in Asia. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Thailand The government’s relationship with the international pharmaceutical industry continues to be uneasy, largely due to the country’s lax patent laws and preferential treatment of domestic producers. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Turkey Turkey accounts for around 40% the total Middle Eastern pharmaceutical market, due to its population of 73 million and large GDP. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Ukraine Although Ukraine represents a potentially major and lucrative pharmaceutical market, most domestic manufacturers are very small and focus on the production of older drugs. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
Apr-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: United Kingdom The UK is one of the leading pharmaceutical producers and exporters in the world. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: USA The USA has the highest health expenditure in the world, but costs need to be contained. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Quarterly updated reports are included in the price, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Venezuela Pharmaceutical market growth in Venezuela is expected to fall as the economy will deepen in recession in 2010. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The Pharmaceutical Market: Vietnam IP laws are still poor in Vietnam. Its industry has little R&D and makes mainly copycat drugs. This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. In addition to the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. More>> |
May-2010 |
£595/
$1040/
€745 |
|
| The World Pharmaceutical Markets Fact Book 2009 Thousands of key market facts and statistics at your fingertips! Bringing together a comprehensive range of often difficult to source information in one publication, the Fact Book includes a global overview, five regional overviews and extensive data on 67 countries. More>> |
Jun-2009 |
£495/
$940/
€745 |
|
| Who's Developing What in Global Biopharmaceuticals? A critical assessment of 50 leading companies, their research, products, partners and performance. More>> |
Sep-2008 |
£695/
$1215/
€870 |